Vogelxo FDA Approval History
FDA Approved: Yes (First approved June 4, 2014)
Brand name: Vogelxo
Generic name: testosterone
Dosage form: Transdermal Gel
Company: Upsher-Smith Laboratories Inc.
Treatment for: Hypogonadism, Male
Vogelxo (testosterone) transdermal gel is an androgen indicated for testosterone replacement therapy in males with hypogonadism.
Development timeline for Vogelxo
| Date | Article |
|---|---|
| Jun 5, 2014 | Approval Upsher-Smith Receives Final NDA Approval For Vogelxo (testosterone) Gel |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
